AT-1501
AT-1501-A201
Phase 2 small_molecule completed
Quick answer
AT-1501 for Amyotrophic Lateral Sclerosis is a Phase 2 program (small_molecule) at Eledon Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Eledon Pharmaceuticals
- Indication
- Amyotrophic Lateral Sclerosis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed